In present study, we performed a comprehensive analysis of sPD-L1 in a cohort of CRC including the patients with lymph node metastasis (n=150) and the patients without lymph node metastasis (n=150), together with a HC control (n=300). The gene discussed is SPDL1; the disease is metastatic malignant neoplasm in the lymph nodes.